BOSTON (Reuters) - Celgene Corp said on Friday that initial results from a clinical trial showed multiple myeloma patients who took its drug Revlimid following a stem cell transplant had a 58 percent reduction in risk of their disease progressing. The company's shares rose nearly 10 percent to $55.60 in afternoon trading on Nasdaq. "We anticipated Revlimid would likely be effective in this setting, but these results come sooner than expected and indicate robust Revlimid benefits," said Brian... Read Full Story
By Christi Myers, abclocal.go.com
There’s one area of medicine where vets may be ahead of physicians — in stem cell therapy for arthritis and joint pain. Some Houston pets are already feeling the effects of stem cells injections. It’s a treatment that’s just become available here. The Canine Health Institute has performed six stem cell transplants on dogs.
Sally is only a year old, but she has so much pain in her hips, she moves like an old dog.
Sally’s owner Charlotte Liberda said... Read Full Story
Asians and Africans may be less likely to benefit from pioneering stem cell research than people of European origin, thanks to a lack of racial diversity in cell stocks, a US study has said. A University of Michigan research team found that stem cell lines came overwhelmingly from individuals of European descent, which could leave the impact of diseases on other races understudied, the team said on Wednesday. "It is crucial that diverse lines are available for this research to ensure that... Read Full Story
Asians and Africans may be less likely to benefit from pioneering stem cell research than people of European origin, thanks to a lack of racial diversity in cell stocks, a US study said Wednesday. A University of Michigan research team found that stem cell lines came overwhelmingly from individuals of European descent, which could leave the impact of diseases on other races understudied, the team said. "It is crucial that diverse lines are available for this research to ensure that all... Read Full Story
Asians and Africans may be less likely to benefit from pioneering stem cell research than people of European origin, thanks to a lack of racial diversity in cell stocks, a US study said Wednesday. A University of Michigan research team found that stem cell lines came overwhelmingly from individuals of European descent, which could leave the impact of diseases on other races understudied, the team said. "It is crucial that diverse lines are available for this research to ensure that all... Read Full Story
Cord blood banks freeze the blood from your babies’ umbilical cords for potential future use against diseases developed by your family. Many serious medical conditions can already be successfully treated by this blood source. Moreover, it is confidently predicted that a plethora of further serious medical conditions will be be able to be cured by the use of the genetic material contained within these cord blood sources. It is well worth evaluating the potential benefits of using a cord blood... Read Full Story
A leading University of Michigan researcher said Tuesday the school now can accept private donations of unused human embryos for creating new stem cell lines. On Wednesday, Dr. Eva Feldman and other researchers will be watching the progress of proposed legislation they fear could hamper their efforts to create those lines and find cures for many diseases. More than a year after Michigan voters approved a ballot proposal that loosened restrictions on embryonic stem cell research by allowing... Read Full Story
With every advancement in the field of cord blood research, the chances of recovery from fatal diseases increases. Hints of latent curing abilities in umbilical cords have made it the subject of microscopic observation for researchers worldwide. Since discovery, its hematopoietic properties have encouraged researchers to take up a number of researches and find its viabilities in a number of diseases. Earlier researches have already come up with huge success in finding and implementing these... Read Full Story
Blacks, other minorities might not gain full benefit from breakthroughs, experts say
Share
What is this?
Buzz
Digg
Facebook
More...
EMAIL
PRINT
RSS
WEDNESDAY, Dec. 16 (HealthDay News) -- Human embryonic stem cell lines currently used for research come mostly from white donors, a new report finds.
That could mean that non-whites will benefit less from any medical breakthroughs that emerge from that research down the... Read Full Story
Well, it is good if you have decided that you want to preserve your child’s umbilical cord blood. You are spending a lot of money on this. Come let’s know how effective these banking measures are. Let us have a quick glance at how the entire process of stem cells preservation works.
Ideally, if preserved properly, it should last for forever. Again, this is debatable, as the concept of cord blood banking is relatively new. It started in the 1970’s, and no sufficient evidence is yet... Read Full Story
